PortfoliosLab logoPortfoliosLab logo
UTHR vs. TREX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

UTHR vs. TREX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and Trex Company, Inc. (TREX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UTHR achieves a 12.05% return, which is significantly lower than TREX's 30.07% return. Over the past 10 years, UTHR has outperformed TREX with an annualized return of 17.67%, while TREX has yielded a comparatively lower 16.02% annualized return.


UTHR

1D
0.10%
1M
-5.79%
YTD
12.05%
6M
10.52%
1Y
90.80%
3Y*
33.49%
5Y*
24.97%
10Y*
17.67%

TREX

1D
-1.53%
1M
20.14%
YTD
30.07%
6M
30.07%
1Y
-20.07%
3Y*
-8.67%
5Y*
-14.60%
10Y*
16.02%
*Multi-year figures are annualized to reflect compound growth (CAGR)

UTHR vs. TREX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UTHR
United Therapeutics Corporation
12.05%38.09%60.46%-20.93%28.70%42.35%72.33%-19.12%-26.39%3.15%
TREX
Trex Company, Inc.
30.07%-49.18%-16.62%95.58%-68.65%61.29%86.29%51.42%9.53%68.31%

Correlation

The correlation between UTHR and TREX is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (5Y)
Calculated over the trailing 5-year period

0.10

Correlation (10Y)
Calculated over the trailing 10-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Jun 17, 1999

0.21

The correlation between UTHR and TREX shifts across timeframes, from 0.10 (5 years) to 0.21 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

UTHR:

$25.77B

TREX:

$4.80B

EPS

UTHR:

$27.00

TREX:

$1.80

PE Ratio

UTHR:

20.22

TREX:

25.41

PEG Ratio

UTHR:

0.66

TREX:

69.84

PS Ratio

UTHR:

8.21

TREX:

4.13

PB Ratio

UTHR:

4.37

TREX:

4.82

Total Revenue (TTM)

UTHR:

$3.17B

TREX:

$1.18B

Gross Profit (TTM)

UTHR:

$2.74B

TREX:

$461.26M

EBITDA (TTM)

UTHR:

$1.75B

TREX:

$308.51M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UTHR vs. TREX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR
UTHR Risk / Return Rank: 9494
Overall Rank
UTHR Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
UTHR Sortino Ratio Rank: 9696
Sortino Ratio Rank
UTHR Omega Ratio Rank: 9494
Omega Ratio Rank
UTHR Calmar Ratio Rank: 9797
Calmar Ratio Rank
UTHR Martin Ratio Rank: 9696
Martin Ratio Rank

TREX
TREX Risk / Return Rank: 2929
Overall Rank
TREX Sharpe Ratio Rank: 2626
Sharpe Ratio Rank
TREX Sortino Ratio Rank: 2828
Sortino Ratio Rank
TREX Omega Ratio Rank: 2727
Omega Ratio Rank
TREX Calmar Ratio Rank: 3131
Calmar Ratio Rank
TREX Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

UTHR vs. TREX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Trex Company, Inc. (TREX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


UTHRTREXDifference
Sharpe ratioReturn per unit of total volatility

+2.32

Sortino ratioReturn per unit of downside risk

+4.43

Omega ratioGain probability vs. loss probability

1.49

0.97

+0.52

Calmar ratioReturn relative to maximum drawdown

8.58

-0.36

+8.94

Martin ratioReturn relative to average drawdown

20.13

-0.57

+20.69

UTHR vs. TREX - Sharpe Ratio Comparison

The current UTHR Sharpe Ratio is 1.92, which is higher than the TREX Sharpe Ratio of -0.39. The chart below compares the historical Sharpe Ratios of UTHR and TREX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

UTHR vs. TREX - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, roughly equal to the maximum TREX drawdown of -90.53%. Use the drawdown chart below to compare losses from any high point for UTHR and TREX.


Loading charts...

Drawdown Indicators


UTHRTREXDifference

Max Drawdown

Largest peak-to-trough decline

-93.18%

-90.53%

-2.65%

Max Drawdown (1Y)

Largest decline over 1 year

-10.64%

-56.01%

+45.37%

Max Drawdown (3Y)

Largest decline over 3 years

-33.00%

-69.90%

+36.90%

Max Drawdown (5Y)

Largest decline over 5 years

-33.00%

-78.58%

+45.58%

Max Drawdown (10Y)

Largest decline over 10 years

-55.56%

-78.58%

+23.02%

Current Drawdown

Current decline from peak

-8.51%

-67.56%

+59.05%

Average Drawdown

Average peak-to-trough decline

-35.31%

-38.76%

+3.45%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.53%

35.58%

-31.05%

Volatility

UTHR vs. TREX - Volatility Comparison

The current volatility for United Therapeutics Corporation (UTHR) is 5.01%, while Trex Company, Inc. (TREX) has a volatility of 15.84%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than TREX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UTHRTREXDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.01%

15.84%

-10.83%

Volatility (6M)

Calculated over the trailing 6-month period

25.94%

28.22%

-2.28%

Volatility (1Y)

Calculated over the trailing 1-year period

47.55%

51.26%

-3.71%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

35.08%

47.34%

-12.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

35.06%

46.46%

-11.40%

Dividends

UTHR vs. TREX - Dividend Comparison

Neither UTHR nor TREX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

UTHR vs. TREX - Financials Comparison

This section allows you to compare key financial metrics between United Therapeutics Corporation and Trex Company, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M300.00M400.00M500.00M600.00M700.00M800.00M20222023202420252026
781.50M
343.40M
(UTHR) Total Revenue
(TREX) Total Revenue
Values in USD except per share items

UTHR vs. TREX - Profitability Comparison

The chart below illustrates the profitability comparison between United Therapeutics Corporation and Trex Company, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20222023202420252026
82.9%
40.5%
Portfolio components
UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.

TREX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Trex Company, Inc. reported a gross profit of 139.02M and revenue of 343.40M. Therefore, the gross margin over that period was 40.5%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.

TREX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Trex Company, Inc. reported an operating income of 83.51M and revenue of 343.40M, resulting in an operating margin of 24.3%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.

TREX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Trex Company, Inc. reported a net income of 61.40M and revenue of 343.40M, resulting in a net margin of 17.9%.


Frequently Asked Questions


UTHR and TREX have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TREX has higher volatility (15.84%) compared to UTHR (5.01%). In terms of maximum drawdown, UTHR dropped -93.18% vs TREX's -90.53%.

UTHR currently has the higher Sharpe Ratio (1.92 vs -0.39), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UTHR and TREX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer